These data demonstrate a major contribution of PR2X7, possibly via activation of the NLRP3 inflammasome, in hepatic inflammation and injury driving transition from steatosis to NASH in the context of NAFLD. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.